Evidence map›Paper›PMID 28120396›Full record

ArticleInternational journal of cancer2017

Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study.

Gordon Fehringer, Darren R Brenner, Zuo-Feng Zhang, Yuan-Chin Amy Lee, Keitaro Matsuo, Hidemi Ito, Qing Lan, Paolo Vineis, Mattias Johansson, Kim Overvad and 46 more

Abstract read
In one paragraph

Article in International journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

56 authors.

Gordon FehringerLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
Darren R BrennerLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
Zuo-Feng ZhangDepartment of Epidemiology, School of Public Health, UCLA, Los Angeles, CA.
Yuan-Chin Amy LeeDepartment of Family and Preventive Medicine, School of Medicine, University of Utah, Salt Lake City, UT.
Keitaro MatsuoDivision of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan.
Hidemi ItoDivision Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
Qing LanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Paolo VineisDivision of Epidemiology, Public Health and Primary Care, Faculty of Medicine, Imperial College London, London, United Kingdom.
Mattias JohanssonInternational Agency for Research on Cancer, Lyon, France.
Kim OvervadDepartment of Public Health, Section for Epidemiology, Aarhus University, Denmark.
Elio RiboliDepartment of Epidemiology and Biostatistics, Imperial College, London, United Kingdom.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Carlotta SacerdoteUnit of Cancer Epidemiology, Piedmont Children Cancer Registry, Città della Salute e della Scienza di Torino Hospital and CPO Piemonte, Turin, Italy.
Isabelle StuckerDepartment of Environmental Epidemiology, INSERM, Villejuif, U170, France.
Paolo BoffettaMount Sinai School of Medicine, The Tisch Cancer Institute, New York, NY.
Paul BrennanInternational Agency for Research on Cancer, Lyon, France.
David C ChristianiHarvard School of Public Health, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
Yun-Chul HongDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Hal MorgensternDepartments of Epidemiology and Environmental Health Sciences, School of Public Health and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI.
Ann G SchwartzKarmanos Cancer Institute, Wayne State University, Detroit, MI.
Angela S WenzlaffKarmanos Cancer Institute, Wayne State University, Detroit, MI.
Gad RennertDepartment of Community Medicine and Epidemiology, Carmel Medical Center and Bruce Rappaport Faculty of Medicine, Israel Institute of Technology and Clalit Health Services National Cancer Control Center, Haifa, Israel.
John R McLaughlinPublic Health Ontario, Toronto, Canada.
Curtis C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD.
Susan Olivo-MarstonCollege of Public Health, The Ohio State University, Columbus, OH.
Irene OrlowDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Bernard J ParkDepartment of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Marjorie ZaudererDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Juan M Barros DiosPreventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Alberto Ruano RaviñaPreventive Medicine and Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain.
Jack SiemiatyckiUniversity of Montreal Hospital Research Center (CRCHUM) and School of Public Health, Montreal, Canada.
Anita KoushikUniversity of Montreal Hospital Research Center (CRCHUM) and School of Public Health, Montreal, Canada.
Philip LazarusDepartment of Pharmaceutical Sciences, College of Pharmacy, Washington State University, Spokane, Washington.
Ana Fernández-SomoanoIUOPA, University Institute of Oncology, University of Oviedo, and CIBERESP, Spain.
Adonina TardonIUOPA, University Institute of Oncology, University of Oviedo, and CIBERESP, Spain.
Loic Le MarchandUniversity of Hawaii Cancer Center, Honolulu, Hawaii.
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Kai-Uwe SaumDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Eric J DuellUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
Angeline S AndrewNorris Cotton Cancer Center, Geisel School of Medicine, Dartmouth College, Lebanon, USA.
Neonila Szeszenia-DabrowskaThe Nofer Institute of Occupational Medicine (NIOM), Lodz, Poland.
Jolanta LissowskaDepartment of Cancer Epidemiology and Prevention, Cancer Center Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland.
David ZaridzeInstitute of Carcinogenesis, Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia.
Peter RudnaiNational Institute of Environmental Health, Budapest, Hungary.
Eleonora FabianovaSpecialized Institute of Hygiene and Epidemiology, Banská Bystrica, Slovakia.
Dana MatesNational Institute of Public Health, Bucharest, Romania.
Lenka ForetovaMasaryk Memorial Cancer Institute, Brno, Czech Republic.
Vladimir JanoutPalacky University, Olomouc, Czech Republic.
Vladimir BenckoInstitute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Ivana HolcatovaInstitute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Angela Cecilia PesatoriEpidemiology Unit, Department of Preventive Medicine, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Dario ConsonniEpidemiology Unit, Department of Preventive Medicine, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-8935-3843
Ann OlssonInternational Agency for Research on Cancer, Lyon, France.
Kurt StraifInternational Agency for Research on Cancer, Lyon, France.
Rayjean J HungLunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI Xin Chen · 1996 to 2026
$56.2M
THE ROLE OF CAL IN CIF-MEDIATED DEGRADATION OF CFTRP20RR018787 · NCRR · DARTMOUTH COLLEGE · PI STANTON, BRUCE A. · 2003 to 2011
$21.9M
Translational studies of Hsp90 inhibitors in NSCLCP50CA090578 · NCI · DANA-FARBER CANCER INST · PI JOHNSON, BRUCE D · 2008 to 2012
$11.4M
Statistical Methods for Analysis of Massive Genetic and Genomic Data in Cancer ResearchR35CA197449 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI XIHONG LIN · 2015 to 2026
$10.9M
Integrative Molecular Epidemiology of Human CancerZIABC011495 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2019
$9.5M
GENETIC EPIDEMIOLOGY OF LUNG CANCERR01CA060691 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G. · 1995 to 2009
$6.2M
Molecular and Genetic Analysis of Lung Cancer SurvivalR01CA092824 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2002 to 2013
$5.9M
SPORE in Lung CancerP20CA090578 · NCI · DANA-FARBER CANCER INSTITUTE · PI JOHNSON, BRUCE E. · 2003 to 2007
$5.1M
GENETIC SUSCEPTIBILITY TO LUNG CANCERR01CA074386 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 1997 to 2008
$4.8M
Adenocarinoma of the Lung in WomenR01CA087895 · NCI · WAYNE STATE UNIVERSITY · PI SCHWARTZ, ANN G · 2001 to 2005
$3.0M
NCI NIH HHS P20 CA090578NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA022453NCI NIH HHS P30 CA071789NCI NIH HHS P50 CA090578NCI NIH HHS R01 CA060691NCI NIH HHS R01 CA074386NCI NIH HHS R01 CA087895NCI NIH HHS R01 CA092824NCI NIH HHS R35 CA197449NCRR NIH HHS P20 RR018787NIEHS NIH HHS R01 ES025460World Health Organization 001
6 · The paper itself

Abstract

It is not clear whether alcohol consumption is associated with lung cancer risk. The relationship is likely confounded by smoking, complicating the interpretation of previous studies. We examined the association of alcohol consumption and lung cancer risk in a large pooled international sample, minimizing potential confounding of tobacco consumption by restricting analyses to never smokers. Our study included 22 case-control and cohort studies with a total of 2548 never-smoking lung cancer patients and 9362 never-smoking controls from North America, Europe and Asia within the International Lung Cancer Consortium (ILCCO) and SYNERGY Consortium. Alcohol consumption was categorized into amounts consumed (grams per day) and also modelled as a continuous variable using restricted cubic splines for potential non-linearity. Analyses by histologic sub-type were included. Associations by type of alcohol consumed (wine, beer and liquor) were also investigated. Alcohol consumption was inversely associated with lung cancer risk with evidence most strongly supporting lower risk for light and moderate drinkers relative to non-drinkers (>0-4.9 g per day: OR = 0.80, 95% CI = 0.70-0.90; 5-9.9 g per day: OR = 0.82, 95% CI = 0.69-0.99; 10-19.9 g per day: OR = 0.79, 95% CI = 0.65-0.96). Inverse associations were found for consumption of wine and liquor, but not beer. The results indicate that alcohol consumption is inversely associated with lung cancer risk, particularly among subjects with low to moderate consumption levels, and among wine and liquor drinkers, but not beer drinkers. Although our results should have no relevant bias from the confounding effect of smoking we cannot preclude that confounding by other factors contributed to the observed associations. Confounding in relation to the non-drinker reference category may be of particular importance.

Indexed as

AgedAlcohol DrinkingAlcoholic BeveragesAsiaCase-Control StudiesCohort StudiesEuropeFemaleHumansLung NeoplasmsMaleMiddle AgedNorth AmericaRisk FactorsSmokingalcoholbeerliquorlung cancerwine

Identifiers

PMID28120396
PMCPMC5356930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.